GENEVA, July 20 -- SEAGEN INC. (21823 30th Drive SEBothell, Washington 98021) filed a patent application (PCT/IB2025/050258) for "ANTIBODY-DRUG CONJUGATES" on Jan 09, 2025. With publication no. WO/2025/149947, the details related to the patent application was published on Jul 17, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ATKINS, Megan Avery (c/o Seagen Inc.21823 30th Drive SEBothell, Washington 98021)
Abstract:
Provided herein are methods for reducing the likelihood and/or severity of peripheral neuropathy, anemia, and/or neutropenia in an individual being treated with an antibody-d...